Tag Archives: IGXT

IntelGenx Technologies (IGXT) Gets a Buy Rating from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on IntelGenx Technologies (Other OTC: IGXT) today and set a price target of $3. The company’s shares opened today at $1.35. McCarthy noted: “IntelGenX announced that it has signed a non-binding

IntelGenx Technologies (IGXT) Receives a Buy from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on IntelGenx Technologies (Other OTC: IGXT), with a price target of $1.50. The company’s shares opened today at $0.73. According to TipRanks.com, Ramakanth is a 4-star

IntelGenx Technologies (IGXT) Receives a Buy from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Buy rating on IntelGenx Technologies (Other OTC: IGXT) today and set a price target of $3. The company’s shares closed yesterday at $0.77. McCarthy observed: “IntelGenX reported 2Q18 with revenue of $234K and

Analysts Offer Insights on Healthcare Companies: IntelGenx Technologies (Other OTC: IGXT) and Vical Inc (NASDAQ: VICL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IntelGenx Technologies (Other OTC: IGXT) and Vical Inc (NASDAQ: VICL) with bullish sentiments. IntelGenx Technologies (Other OTC: IGXT) H.C. Wainwright analyst Swayampakula

Analysts Offer Insights on Healthcare Companies: IntelGenx Technologies (Other OTC: IGXT) and Durect Corp (NASDAQ: DRRX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IntelGenx Technologies (Other OTC: IGXT) and Durect Corp (NASDAQ: DRRX) with bullish sentiments. IntelGenx Technologies (Other OTC: IGXT) H.C. Wainwright analyst Swayampakula

H.C. Wainwright Reiterates a Buy Rating on IntelGenx Technologies

In a report released yesterday, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on IntelGenx Technologies (OTHEROTC: IGXT). The company’s shares closed yesterday at $0.56. IntelGenx Technologies has an analyst consensus of Moderate Buy. IntelGenx Technologies` market cap is